664
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis

, , , , ORCID Icon, , , & ORCID Icon show all
Pages 503-513 | Received 06 Oct 2016, Accepted 17 Mar 2017, Published online: 29 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Min-Yue Zhang, Fei Gao, Yan-Wei Zhao, Bei-Wen Ni, Hong-Hui Huang & Jian Hou. (2022) Inferior survival and frequent hepatic dysfunction in non-Hodgkin’s lymphoma patients with HBV infection: a systematic review and meta-analysis. Hematology 27:1, pages 70-79.
Read now
Mario Fernández-Ruiz & José María Aguado. (2018) Risk of infection associated with anti-TNF-α therapy. Expert Review of Anti-infective Therapy 16:12, pages 939-956.
Read now

Articles from other publishers (13)

Joyce Wing Yan Mak, Alvin Wing Hin Law, Kimmy Wan Tung Law, Rita Ho, Carmen Ka Man Cheung & Man Fai Law. (2023) Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era. World Journal of Gastroenterology 29:33, pages 4942-4961.
Crossref
Ya-Li Wu, Jing Ke, Bao-Yu Zhang & Dong Zhao. (2022) Hepatitis B virus reactivation in rheumatoid arthritis. World Journal of Clinical Cases 10:1, pages 12-22.
Crossref
Fei Gao, Mei-Si Lin, Jie-Shu You, Min-Yue Zhang, Long Cheng, Ke Lin, Peng Zhao & Qi-Yan Chen. (2021) Long-term outcomes of busulfan plus melphalan-based versus melphalan 200 mg/m2 conditioning regimens for autologous hematopoietic stem cell transplantation in patients with multiple myeloma: a systematic review and meta-analysis. Cancer Cell International 21:1.
Crossref
Minyue Zhang, Fei Gao, Ling Peng, Lijing Shen, Peng Zhao, Beiwen Ni, Jian Hou & Honghui Huang. (2021) Distinct clinical features and prognostic factors of hepatitis C virus-associated non-Hodgkin’s lymphoma: a systematic review and meta-analysis. Cancer Cell International 21:1.
Crossref
Bilal Toka, Aydin Seref Koksal, Ahmet Tarik Eminler, Mukaddes Tozlu, Mustafa Ihsan Uslan & Erkan Parlak. (2020) Comparison of Tenofovir Disoproxil Fumarate and Entecavir in the Prophylaxis of HBV Reactivation. Digestive Diseases and Sciences 66:7, pages 2417-2426.
Crossref
Hamdi Akan, Tony Bruns & Mathias W. Pletz. 2021. Infection Management in Hematology. Infection Management in Hematology 57 75 .
Sebahat CamMustafa Asim Yoruk. (2020) Alteration in Hepatitis B Serology in Children Receiving Chemotherapy. Viral Immunology 33:10, pages 628-633.
Crossref
Lan-Ying He, Yu-Lan WangXu Tian & Wei-Qing Chen. (2020) The association of hepatitis B virus screening and antiviral prophylaxis with adverse liver outcomes in Chinese cancer patients undergoing chemotherapy. Medicine 99:14, pages e19647.
Crossref
Wei Wang, Shilin-L. Tian, Hui Wang, Chun-Chun Shao, Yong-Zheng Wang & Yu-Liang Li. (2020) Association of Hepatitis B Virus DNA Level and Follow-up Interval With Hepatocellular Carcinoma Recurrence. JAMA Network Open 3:4, pages e203707.
Crossref
Jiang Su, Li Long & Kun Zou. (2018) Antiviral prophylaxis for preventing reactivation of hepatitis B virus in rheumatic patients: a systematic review and meta-analysis. Clinical Rheumatology 37:12, pages 3201-3214.
Crossref
Yi-Chia Su, Pei-Chin Lin, Hsien-Chung Yu & Chih-Chien Wu. (2018) Antiviral prophylaxis during chemotherapy or immunosuppressive drug therapy to prevent HBV reactivation in patients with resolved HBV infection: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 74:9, pages 1111-1119.
Crossref
Aida Siyahian, Saad Ullah Malik, Adeela Mushtaq, Carol L. Howe, Aneela Majeed, Tirdad Zangeneh, Samar Iftikhar, Shahid Habib, Umar Zahid, Irbaz Bin Riaz, Zabih Warraich, Warda Faridi & Faiz Anwer. (2018) Prophylaxis for Hepatitis B Virus Reactivation after Allogeneic Stem Cell Transplantation in the Era of Drug Resistance and Newer Antivirals: A Systematic Review and Meta-Analysis. Biology of Blood and Marrow Transplantation 24:7, pages 1483-1489.
Crossref
Zilin Tang, Xiaodong Li, Shunquan Wu, Yan Liu, Yan Qiao, Dongping Xu & Jin Li. (2017) Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis. Hepatology International 11:5, pages 429-433.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.